American Research & Management Co. Novartis Ag Call Options Transaction History
American Research & Management Co.
- $362 Million
- Q3 2022
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding NVS
# of Institutions
1,426Shares Held
138MCall Options Held
1.48MPut Options Held
1.54M-
Dodge & Cox San Francisco, CA12.2MShares$1.4 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.4 Billion0.95% of portfolio
-
Morgan Stanley New York, NY7.42MShares$850 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.41MShares$849 Million0.21% of portfolio
-
Loomis Sayles & CO L P5.95MShares$681 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $246B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...